Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases.
Konstantinos P ExarchosGeorgia GkrepiKonstantinos KostikasAthena GogaliPublished in: Diagnostics (Basel, Switzerland) (2023)
Interstitial lung diseases (ILDs) comprise a rather heterogeneous group of diseases varying in pathophysiology, presentation, epidemiology, diagnosis, treatment and prognosis. Even though they have been recognized for several years, there are still areas of research debate. In the majority of ILDs, imaging modalities and especially high-resolution Computed Tomography (CT) scans have been the cornerstone in patient diagnostic approach and follow-up. The intricate nature of ILDs and the accompanying data have led to an increasing adoption of artificial intelligence (AI) techniques, primarily on imaging data but also in genetic data, spirometry and lung diffusion, among others. In this literature review, we describe the most prominent applications of AI in ILDs presented approximately within the last five years. We roughly stratify these studies in three categories, namely: (i) screening, (ii) diagnosis and classification, (iii) prognosis.
Keyphrases
- artificial intelligence
- big data
- machine learning
- high resolution
- deep learning
- computed tomography
- electronic health record
- case report
- dual energy
- positron emission tomography
- contrast enhanced
- magnetic resonance imaging
- image quality
- mass spectrometry
- magnetic resonance
- gene expression
- genome wide
- chronic obstructive pulmonary disease
- copy number
- lung function
- high speed
- pet ct
- combination therapy